Physician profile
Corwin A Thomas
NPI 1013920362
$30,188.13
in general payments reported to CMS, 2019-2025
47 companies · $1,358 in 2025
The $1,358 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,711 · 2020: $2,323 · 2021: $8,622 · 2022: $6,794 · 2023: $6,132 · 2024: $3,248 · 2025: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $6,600 · Food and Beverage: $3,937 · Travel and Lodging: $181 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $6,600.00 |
| Food and Beverage | $3,936.64 |
| Travel and Lodging | $181.31 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $15,180.16 | 2020-2024 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $2,683.18 | 2022 | |
| Abiomed | $1,032.73 | 2020-2025 | Impella |
| Boston Scientific Corporation | $919.72 | 2019-2025 | Angiojet Ultra 5000a, Innova Vascular, Rubicon 18 |
| Janssen Pharmaceuticals, INC | $896.15 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $758.72 | 2019-2025 | Lifevest |
| Philips North America LLC | $645.38 | 2019-2025 | (Am5) Lead Management, Eagle Eye, (6582) Visions 035 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $638.15 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $605.13 | 2019-2024 | Farxiga |
| Pfizer INC. | $551.96 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $531.18 | 2019-2024 | Leqvio |
| Bayer Healthcare Pharmaceuticals INC. | $525.34 | 2021-2025 | |
| Amgen INC. | $516.31 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $478.21 | 2021-2025 | |
| Esperion Therapeutics, INC. | $462.79 | 2021-2025 | Nexletol |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $449.56 | 2021-2024 | Onyx Frontier, In.Pact Admiral, Abre |
| Novo Nordisk INC | $387.23 | 2019-2025 | Wegovy, Ozempic |
| Cardiovascular Systems INC. | $361.32 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $353.35 | 2021-2025 | Verquvo, Capvaxive |
| Abbott Laboratories | $226.65 | 2022-2025 | Diamondback Coronary, Esprit, Jot Dx |
| Regeneron Healthcare Solutions, INC. | $217.94 | 2019-2023 | Evkeeza |
| United Therapeutics Corporation | $198.35 | 2019-2020 | |
| Baxter Healthcare | $179.60 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Kowa Pharmaceuticals America, INC. | $174.69 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $147.78 | 2019-2023 | |
| Avinger INC. | $124.47 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $121.60 | 2020-2022 | |
| Atricure, INC. | $93.30 | 2022-2024 | |
| Arbor Pharmaceuticals, INC. | $93.07 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $84.00 | 2022-2025 | Venovo, Fluency Endovascular Stent Graft |
| Amryt Pharma Holdings Ltd | $69.26 | 2022 | |
| Amarin Pharma, INC. | $53.74 | 2019-2022 | |
| Lundbeck LLC | $44.08 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $42.67 | 2025 | Assure Wcd |
| W. L. Gore & Associates, INC. | $40.95 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis |
| Daiichi Sankyo INC. | $40.68 | 2023 | Injectafer |
| Gilead Sciences, INC. | $39.78 | 2019 | |
| Endo Pharmaceuticals INC. | $33.04 | 2020-2021 | |
| Cordis US Corp. | $31.01 | 2023-2024 | Mynx Venous Vcd, Saber |
| Currax Pharmaceuticals LLC | $30.21 | 2019-2020 | |
| Surmodics, INC. | $23.16 | 2022-2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Xeris Pharmaceuticals, INC. | $21.12 | 2022 | |
| Inspire Medical Systems, INC. | $19.07 | 2025 | Inspire |
| Chiesi USA, INC. | $18.04 | 2025 | Juxtapid |
| Actelion Pharmaceuticals US, INC. | $17.52 | 2025 | Opsumit |
| Lexicon Pharmaceuticals, INC. | $13.03 | 2023 | Inpefa |
| Veryan Medical Incorporated | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corwin Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.